Neuronoff

Focus: Neuronoff is a Cleveland-based medical device company specializing in pain relief implants, specifically neuromodulation injectrodes for chronic pain management. The company is early-stage with minimal public financial disclosure.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Total Funding

$4.5M

Open Jobs

About Neuronoff

AI assessmentNot Hiring

No open roles listed right now. Follow Neuronoff to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Neuronoff BASMATI Injectrode

Chronic Lower Limb Pain

N/A

Clinical Trials (1)

NCT04672096Basic Assessment of Safety and Minimally Invasive Stimulation Via Injectrode

N/A

Help build intelligence for Neuronoff

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to develop novel implantable technology in the large chronic pain market with two active programs
Early-stage position offers potential equity upside if neuromodulation injectrode technology gains FDA traction
Specialized medical device focus provides differentiated skill-building vs. pharma-only career track

Watch Out For

No current job openings (activeJobCount = 0) suggests company is not actively hiring or in early/stalled growth phase
Extremely early pipeline with only Phase 1 data; no Phase 2/3 programs limits near-term clinical validation and revenue visibility
Missing critical data on funding, financials, and headcount raises transparency concerns about company stability and resources

Generated by Claude from Neuronoff's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

PNS Injectrode F1

Chronic Pain

Phase 1

Clinical Trials (1)

NCT06206356Lumbar Injectrode Feasibility Evaluation

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo